{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:52:18Z","timestamp":1791355938924,"version":"4.3.1"},"reference-count":45,"publisher":"Impact Journals, LLC","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,6,14]]},"DOI":"10.18632\/oncotarget.9371","type":"journal-article","created":{"date-parts":[[2016,5,15]],"date-time":"2016-05-15T00:50:58Z","timestamp":1463273458000},"page":"35946-35959","source":"Crossref","is-referenced-by-count":36,"title":["The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia"],"prefix":"10.18632","volume":"7","author":[{"given":"Nikos","family":"Papakonstantinou","sequence":"first","affiliation":[{"name":"Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece"},{"name":"Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavroula","family":"Ntoufa","sequence":"additional","affiliation":[{"name":"Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece"},{"name":"Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisavet","family":"Chartomatsidou","sequence":"additional","affiliation":[{"name":"Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantia","family":"Kotta","sequence":"additional","affiliation":[{"name":"Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Agathangelidis","sequence":"additional","affiliation":[{"name":"Division of Experimental Oncology and Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute and Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lefki","family":"Giassafaki","sequence":"additional","affiliation":[{"name":"Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzeni","family":"Karamanli","sequence":"additional","affiliation":[{"name":"Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Bele","sequence":"additional","affiliation":[{"name":"Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Moysiadis","sequence":"additional","affiliation":[{"name":"Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Baliakas","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley Ann","family":"Sutton","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Stavroyianni","sequence":"additional","affiliation":[{"name":"Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achilles","family":"Anagnostopoulos","sequence":"additional","affiliation":[{"name":"Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios M.","family":"Makris","sequence":"additional","affiliation":[{"name":"Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ghia","sequence":"additional","affiliation":[{"name":"Division of Experimental Oncology and Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute and Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Rosenquist","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[{"name":"Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece"},{"name":"Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden"},{"name":"Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,5,14]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc2876","article-title":"Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers","volume":"10","author":"Wang","year":"2010","journal-title":"Nature reviews Cancer"},{"key":"2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrd3674","article-title":"Epigenetic protein families: a new frontier for drug discovery","volume":"11","author":"Schapira","year":"2012","journal-title":"Nature reviews Drug discovery"},{"key":"3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.stem.2010.08.002","article-title":"Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer","volume":"7","author":"Sauvageau","year":"2010","journal-title":"Cell stem cell"},{"key":"4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mrfmmm.2008.07.010","article-title":"Roles of the EZH2 histone methyltransferase in cancer epigenetics","volume":"647","author":"Lange","year":"2008","journal-title":"Mutation research"},{"key":"5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/bjc.2011.551","article-title":"The role of EZH2 in tumour progression","volume":"106","author":"Hung","year":"2012","journal-title":"British journal of cancer"},{"key":"6","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3324\/haematol.2010.028605","article-title":"Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia\/lymphoma as a target for epigenetic therapy","volume":"96","author":"Yamada","year":"2011","journal-title":"Haematologica"},{"key":"7","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1258\/ebm.2012.012075","article-title":"Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia","volume":"237","author":"Zhao","year":"2012","journal-title":"Experimental biology and medicine"},{"key":"8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1182\/blood-2011-11-394932","article-title":"Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia","volume":"120","author":"Iwama","year":"2012","journal-title":"Blood"},{"key":"9","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2012-08-450494","article-title":"EZH2 overexpression in natural killer\/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity","volume":"121","author":"Chng","year":"2013","journal-title":"Blood"},{"key":"10","first-page":"243","article-title":"The roles of EZH2 in cell lineage commitment","volume":"3","author":"Hung","year":"2011","journal-title":"American journal of translational research"},{"key":"11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/leu.2013.288","article-title":"EZH2 in normal and malignant hematopoiesis","volume":"28","author":"Copland","year":"2014","journal-title":"Leukemia"},{"key":"12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ni876","article-title":"Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement","volume":"4","author":"Tarakhovsky","year":"2003","journal-title":"Nature immunology"},{"key":"13","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/eji.200424985","article-title":"Distinct expression patterns of polycomb oncoproteins and their binding partners during the germinal center reaction","volume":"34","author":"Raaphorst","year":"2004","journal-title":"European journal of immunology"},{"key":"14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Kimbara","year":"2010","journal-title":"Nature genetics"},{"key":"15","first-page":"115","article-title":"Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia","volume":"19","author":"Stamatopoulos","year":"2013","journal-title":"Molecular medicine (Cambridge, MA)"},{"key":"16","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood-2010-07-155663","article-title":"Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities","volume":"117","author":"Ferrarini","year":"2011","journal-title":"Blood"},{"key":"17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","article-title":"Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations","volume":"109","author":"Montserrat","year":"2007","journal-title":"Blood"},{"key":"18","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S2352-3026(14)00005-2","article-title":"Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study","volume":"1","author":"Tzenou","year":"2014","journal-title":"The Lancet Haematology"},{"key":"19","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1182\/blood-2011-11-393694","article-title":"Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies","volume":"119","author":"Bonello","year":"2012","journal-title":"Blood"},{"key":"20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-62703-269-8_8","article-title":"Stereotyped B cell receptors in B cell leukemias and lymphomas","volume":"971","author":"Stamatopoulos","year":"2013","journal-title":"Methods in molecular biology"},{"key":"21","article-title":"Stereotyped B-cell receptors in chronic lymphocytic leukemia","author":"Stamatopoulos","year":"2014","journal-title":"Leukemia & lymphoma"},{"key":"22","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S2352-3026(14)00005-2","article-title":"Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukemia: a retrospective multicentre study","volume":"1","author":"Tzenou","year":"2014","journal-title":"Lancet Haematol"},{"key":"23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrc2931","article-title":"Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins","volume":"10","author":"Mills","year":"2010","journal-title":"Nature reviews Cancer"},{"key":"24","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3324\/haematol.2011.044792","article-title":"Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients","volume":"96","author":"Belessi","year":"2011","journal-title":"Haematologica"},{"key":"25","first-page":"1281","article-title":"Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors","volume":"18","author":"Stamatopoulos","year":"2012","journal-title":"Molecular medicine (Cambridge, Mass"},{"key":"26","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1182\/blood-2014-09-600874","article-title":"Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations","volume":"125","author":"Chatzouli","year":"2015","journal-title":"Blood"},{"key":"27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4143\/crt.2014.46.3.209","article-title":"Regulation and Role of EZH2 in Cancer","volume":"46","author":"Hung","year":"2014","journal-title":"Cancer research and treatment"},{"key":"28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Tubio","year":"2011","journal-title":"Nature"},{"key":"29","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1084\/jem.20110921","article-title":"Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation","volume":"208","author":"Paulli","year":"2011","journal-title":"The Journal of experimental medicine"},{"key":"30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia","volume":"44","author":"Rozman","year":"2012","journal-title":"Nature genetics"},{"key":"31","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1126\/science.1165395","article-title":"Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer","volume":"322","author":"Kumar-Sinha","year":"2008","journal-title":"Science (New York, NY"},{"key":"32","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood-2002-06-1822","article-title":"Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia","volume":"101","author":"Packham","year":"2003","journal-title":"Blood"},{"key":"33","doi-asserted-by":"crossref","first-page":"e1004642","DOI":"10.1371\/journal.pgen.1004642","article-title":"Regulation of p53 and Rb links the alternative NF-kappaB pathway to EZH2 expression and cell senescence","volume":"10","author":"Perkins","year":"2014","journal-title":"PLoS genetics"},{"key":"34","doi-asserted-by":"crossref","first-page":"31693","DOI":"10.1074\/jbc.M114.574517","article-title":"c-Rel regulates Ezh2 expression in activated lymphocytes and malignant lymphoid cells","volume":"289","author":"Su","year":"2014","journal-title":"The Journal of biological chemistry"},{"key":"35","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1038\/cddis.2011.84","article-title":"Roles of the Polycomb group proteins in stem cells and cancer","volume":"2","author":"Di Croce","year":"2011","journal-title":"Cell death & disease"},{"key":"36","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.4161\/epi.26546","article-title":"A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma","volume":"8","author":"Rosenquist","year":"2013","journal-title":"Epigenetics"},{"key":"37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrd3937","article-title":"Targeting pathological B cell receptor signalling in lymphoid malignancies","volume":"12","author":"Staudt","year":"2013","journal-title":"Nature reviews Drug discovery"},{"key":"38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00428-013-1428-y","article-title":"In aggressive variants of non-Hodgkin lymphomas, Ezh2 is strongly expressed and polycomb repressive complex PRC1.4 dominates over PRC1.2","volume":"463","author":"Yoshino","year":"2013","journal-title":"Virchows Archiv"},{"key":"39","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1158\/1535-7163.MCT-13-0773","article-title":"Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma","volume":"13","author":"Smith","year":"2014","journal-title":"Molecular cancer therapeutics"},{"key":"40","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Kipps","year":"2008","journal-title":"Blood"},{"key":"41","doi-asserted-by":"crossref","first-page":"D1006","DOI":"10.1093\/nar\/gkn838","article-title":"IMGT, the international ImMunoGeneTics information system","volume":"37","author":"Duroux","year":"2009","journal-title":"Nucleic acids research"},{"key":"42","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrclinonc.2014.137","article-title":"Precision therapy for lymphoma\u2014current state and future directions","volume":"11","author":"Younes","year":"2014","journal-title":"Nature reviews Clinical oncology"},{"key":"43","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Schmittgen","year":"2001","journal-title":"Methods (San Diego, Calif"},{"key":"44","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.cell.2011.09.057","article-title":"Combinatorial patterning of chromatin regulators uncovered by genome-wide location analysis in human cells","volume":"147","author":"Bernstein","year":"2011","journal-title":"Cell"},{"key":"45","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Zhang","year":"2014","journal-title":"Nature methods"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T21:15:47Z","timestamp":1589231747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,14]]},"references-count":45,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2016,6,14]]}},"alternative-id":["9371","27191993"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9371","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,14]]}}}